{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:32:32Z","timestamp":1791149552110,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T00:00:00Z","timestamp":1679270400000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Pharmacokinet"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s40262-023-01226-6","type":"journal-article","created":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T09:03:13Z","timestamp":1679302993000},"page":"399-434","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Pharmacokinetics and Target Attainment of Antimicrobial Drugs Throughout Pregnancy: Part III Non-penicillin and Non-cephalosporin Drugs"],"prefix":"10.1007","volume":"62","author":[{"given":"F.","family":"Groen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. R.","family":"Prins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. N. Lub-de","family":"Hooge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. L. J.","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. G. W.","family":"Kosterink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. J.","family":"Touw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3551-1201","authenticated-orcid":false,"given":"P.","family":"Mian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,20]]},"reference":[{"issue":"6","key":"1226_CR1","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1177\/1060028018817935","volume":"53","author":"H Rac","year":"2019","unstructured":"Rac H, Gould AP, Eiland LS, Griffin B, McLaughlin M, Stover KR, et al. Common bacterial and viral infections: review of management in the pregnant patient. Ann Pharmacother. 2019;53(6):639\u201351.","journal-title":"Ann Pharmacother."},{"issue":"23","key":"1226_CR2","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1056\/NEJMra1213566","volume":"370","author":"AP Kourtis","year":"2014","unstructured":"Kourtis AP, Read JS, Jamieson DJ. Pregnancy and infection. N Engl J Med. 2014;370(23):2211\u20138.","journal-title":"N Engl J Med"},{"issue":"1","key":"1226_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/FTD.0000000000000950","volume":"44","author":"J Stojanova","year":"2022","unstructured":"Stojanova J, Arancibia M, Ghimire S, Sandaradura I. Understanding the pharmacokinetics of antibiotics in pregnancy: is there a role for therapeutic drug monitoring? A narrative review. Ther Drug Monit. 2022;44(1):50\u201364.","journal-title":"Ther Drug Monit."},{"issue":"11","key":"1226_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002160","volume":"13","author":"G Pariente","year":"2016","unstructured":"Pariente G, Leibson T, Caris A, Adams-Webber T, Ito S, Koren G. Pregnancy-associated changes in pharmacokinetics: a systematic review. PLoS med. 2016;13(11): e1002160.","journal-title":"PLoS med"},{"issue":"5","key":"1226_CR5","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2174\/1381612825666190320135137","volume":"25","author":"A Dallmann","year":"2019","unstructured":"Dallmann A, Mian P, van den Anker J, Allegaert K. Clinical pharmacokinetic studies in pregnant women and relevance of pharmacometric tools. Curr Pharm Des. 2019;25(5):483\u201395.","journal-title":"Curr Pharm Des"},{"key":"1226_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-023-01211-z","author":"MR Hesse","year":"2023","unstructured":"Hesse MR, Prins JR, Hooge MNLd, et al. Pharmacokinetics and target attainment of antimicrobial drugs throughout pregnancy: part I\u2014penicillins. Clin Pharmacokinet. 2023. https:\/\/doi.org\/10.1007\/s40262-023-01211-z.","journal-title":"Clin Pharmacokinet"},{"key":"1226_CR7","unstructured":"PRISMA Guideline. 2020. https:\/\/prisma-statement.org\/PRISMAStatement\/CitingAndUsingPRISMA. Accessed 01 Sep 2021"},{"issue":"9","key":"1226_CR8","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/sj.bdj.4811224","volume":"196","author":"MN Pemberton","year":"2004","unstructured":"Pemberton MN, Oliver RJ, Theaker ED. Miconazole oral gel and drug interactions. Br Dent J. 2004;196(9):529\u201331.","journal-title":"Br Dent J"},{"issue":"5","key":"1226_CR9","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/jac\/dki079","volume":"55","author":"JW Mouton","year":"2005","unstructured":"Mouton JW, Dudley MN, Cars O, Derendorf H, Drusano GL. Standardization of pharmacokinetic\/pharmacodynamic (PK\/PD) terminology for anti-infective drugs: an update. J Antimicrob Chemother. 2005;55(5):601\u20137.","journal-title":"J Antimicrob Chemother."},{"issue":"6","key":"1226_CR10","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/j.1365-2710.2007.00864.x","volume":"32","author":"J Popov\u00edc","year":"2007","unstructured":"Popov\u00edc J, Grujic Z, Sabo A. Influence of pregnancy on ceftriaxone, cefazolin and gentamicin pharmacokinetics in caesarean vs. non-pregnant sectioned women. J Clin Pharm Ther. 2007;32(6):595\u2013602.","journal-title":"J Clin Pharm Ther."},{"issue":"3","key":"1226_CR11","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1365-2710.1991.tb00300.x","volume":"16","author":"P Bourget","year":"1991","unstructured":"Bourget P, Fernandez H, Delouis C, Taburet AM. Pharmacokinetics of tobramycin in pregnant women. Safety and efficacy of a once-daily dose regimen. J Clin Pharm Ther. 1991;16(3):167\u201376.","journal-title":"J Clin Pharm Ther."},{"issue":"992","key":"1226_CR12","first-page":"4","volume":"76","author":"H Fernandez","year":"1990","unstructured":"Fernandez H, Bourgt P, Delouis C. Fetal levels of tobramycin following maternal administration. Obstet Gynecol. 1990;76(992):4.","journal-title":"Obstet Gynecol"},{"issue":"12","key":"1226_CR13","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1128\/AAC.36.12.2652","volume":"36","author":"A Heikkila","year":"1992","unstructured":"Heikkila A, Renkonen OV, Erkkola R. Pharmacokinetics and transplacental passage of imipenem during pregnancy. Antimicrob Agents Chemther. 1992;36(12):2652\u20135.","journal-title":"Antimicrob Agents Chemther."},{"issue":"5A","key":"1226_CR14","doi-asserted-by":"publisher","first-page":"49S","DOI":"10.1016\/0002-9343(89)90021-1","volume":"87","author":"H Giamarellou","year":"1989","unstructured":"Giamarellou H, Kolokythas E, Petrikkos G, Gazis J, Aravantinos D, Sfikakis P. Pharmacokinetics of three newer quinolones in pregnant and lactation women. Am J Med. 1989;87(5A):49S-51S.","journal-title":"Am J Med"},{"issue":"2","key":"1226_CR15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ijantimicag.2010.03.011","volume":"36","author":"O Ozyuncu","year":"2010","unstructured":"Ozyuncu O, Nemutlu E, Katlan D, Kir S, Beksac M. Maternal and fetal blood levels of moxifloxacin, levofloxacin, cefepime and cefoperazone. Int J Antimicrob Agents. 2010;36(2):175\u20138.","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"1226_CR16","doi-asserted-by":"publisher","first-page":"1601724","DOI":"10.1183\/13993003.01724-2016","volume":"49","author":"E Van Kampenhout","year":"2017","unstructured":"Van Kampenhout E, Bolhuis MS, Alffenaar J-WC, Oswals LMA, Kerstjens HAM, et al. Pharmacokinetics of moxifloxacin and linezolid during and after pregnancy in a patient with multidrug-resistant tuberculosis. Eur Respir J. 2017;49(3):1601724.","journal-title":"Eur Respir J."},{"issue":"6","key":"1226_CR17","doi-asserted-by":"publisher","first-page":"502","DOI":"10.2174\/138620710791516003","volume":"13","author":"E Nemutlu","year":"2010","unstructured":"Nemutlu E, Kir S, Eroglu H, Katlan D, Ozek A, Ozyuncu O, et al. Comparison of pharmacokinetic profles of moxifloxacin in Caesarean versus non-pregnant sectioned women by fully validated HPLC with fluorescence detection. Comb Chem High Throughput Screen. 2010;13(6):502\u20139.","journal-title":"Comb Chem High Throughput Screen"},{"issue":"5 pt 2","key":"1226_CR18","first-page":"908","volume":"78","author":"P Bourget","year":"1991","unstructured":"Bourget P, Fernandez H, Delious C, Ribou F. Transplacental passage of vancomycin during the second trimester of pregnancy. Obstet Gynecol. 1991;78(5 pt 2):908\u201311.","journal-title":"Obstet Gynecol"},{"issue":"5","key":"1226_CR19","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1097\/01.AOG.0000260388.78339.b6","volume":"109","author":"J Laiprasert","year":"2007","unstructured":"Laiprasert J, Klein K, Mueller BA, Pearlman MD. Transplacental passage of vancomycin in noninfected term pregnant women. Obstet Gynecol. 2007;109(5):1105\u201310.","journal-title":"Obstet Gynecol."},{"issue":"4","key":"1226_CR20","doi-asserted-by":"publisher","first-page":"352.e1","DOI":"10.1016\/j.ajog.2014.01.019","volume":"210","author":"CN Onwuchuruba","year":"2014","unstructured":"Onwuchuruba CN, Towers CV, Howard BC, Hennessy MD, Wolfe L, Brown MS. Transplacental passage of vancomycin from mother to neonate. Am J Obstet Gynecol. 2014;210(4):352.e1-352.e4.","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"1226_CR21","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1080\/14767058.2017.1306049","volume":"31","author":"CV Towers","year":"2018","unstructured":"Towers CV, Weit B. J Transplacental passage of vancomycin. Matern Fetal Neonatal Med. 2018;31(8):1021\u20134.","journal-title":"Matern Fetal Neonatal Med"},{"issue":"3","key":"1226_CR22","first-page":"1243","volume":"60","author":"P Denti","year":"2015","unstructured":"Denti P, Martinson N, Cohn S, Mashabela F, Hoffmann J, Msandiwa R, et al. Population pharmacokinetics of rifampicin in pregnant women with tuberculosis and HIV coinfection in Soweto, South Africa. Antimicrob Agents Chemother. 2015;60(3):1243\u2013341.","journal-title":"Antimicrob Agents Chemother."},{"issue":"9","key":"1226_CR23","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1093\/cid\/ciab665","volume":"74","author":"JS Mathad","year":"2022","unstructured":"Mathad JS, Savic R, Britto P, Jayachandran P, Wiesner L, Montepiedra G, et al. Pharmacokinetics and safety of 3 months of weekly rifapentine and isoniazid for tuberculosis prevention in pregnant women. Clin Infect Dis. 2022;74(9):1604\u201313.","journal-title":"Clin Infect Dis"},{"issue":"112","key":"1226_CR24","first-page":"67","volume":"14","author":"DW Reid","year":"1975","unstructured":"Reid DW, Caille G, Kaufmann NR. Maternal and transplacental kinetics of trimethoprim and sulfamethoxazole, separately and in combination. Can Med Assoc J. 1975;14(112):67\u201372.","journal-title":"Can Med Assoc J"},{"issue":"3","key":"1226_CR25","doi-asserted-by":"publisher","first-page":"e01978","DOI":"10.1128\/AAC.01978-19","volume":"64","author":"MT Abdelwahab","year":"2020","unstructured":"Abdelwahab MT, Leisegang R, Dolley KE, Mathat JS, Wiesner L, Mclleron H, et al. Population pharmacokinetics of isoniazid, pyrazinamide, ethambutol in pregnant south African women with tuberculosis and HIV. Antimicrob Agents Chemother. 2020;64(3):e01978-e2019.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"1226_CR26","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1002\/cpt.2044","volume":"109","author":"K Gausi","year":"2021","unstructured":"Gausi K, Wiesner L, Norman J, Wallis CL, Onyango-Makumbi C, Chipato T, et al. Pharmacokinetics and drug-drug interactions of isoniazid and efavirenz in pregnant women living with HIV in high TB incidence settings: importance of genotyping. Clin Pharmacol Ther. 2021;109(4):1034\u201344.","journal-title":"Clin Pharmacol Ther."},{"issue":"7","key":"1226_CR27","doi-asserted-by":"publisher","first-page":"4460451","DOI":"10.1016\/j.jiac.2017.03.015","volume":"23","author":"S Harauchi","year":"2017","unstructured":"Harauchi S, Osawa T, Kubono N, Itoh H, Naito T, Kawakami J. Transfer of vaginal chloramphenicol to circulating blood in pregnant women and its relationship with their maternal background and neonatal health. J Infect Chemother. 2017;23(7):4460451.","journal-title":"J Infect Chemother"},{"issue":"5","key":"1226_CR28","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1128\/AAC.01017-09","volume":"54","author":"AE Muller","year":"2010","unstructured":"Muller AE, Mouton JW, Oostvogel PM, Dorr PJ, Voskuyl RA, DeJongh J, et al. Pharmacokinetics of clindamycin in pregnant women in the peripartum period. Antimicrob Agents Chemother. 2010;54(5):2175\u201381.","journal-title":"Antimicrob Agents Chemother."},{"issue":"23","key":"1226_CR29","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1056\/NEJM197306072882307","volume":"288","author":"A Philipson","year":"1973","unstructured":"Philipson A, Sabath LD, Charles D. Transplacental passage of erythromycin and clindamycin. N engl J Med. 1973;288(23):1219\u201321.","journal-title":"N engl J Med"},{"issue":"11","key":"1226_CR30","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/jp.2016.122","volume":"36","author":"CD Wear","year":"2016","unstructured":"Wear CD, Towers CV, Brown MS, Weitz B, Porter S, Wolfe L. Transplacental passage of clindamycin from mother to neonate. J Perinatol. 2016;36(11):960\u20131.","journal-title":"J Perinatol"},{"issue":"2","key":"1226_CR31","first-page":"265","volume":"25","author":"JE Perry","year":"1967","unstructured":"Perry JE, Leblanc AL. Transfer of nitrofurantoin across the human placenta. Tex Rep Biol Med. 1967;25(2):265\u20139.","journal-title":"Tex Rep Biol Med."},{"key":"1226_CR32","volume-title":"Drugs in pregnancy and lactation","author":"GG Briggs","year":"2017","unstructured":"Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. 11th ed. Philadelphia: Lippincott Williams & Wilkins; 2017.","edition":"11"},{"issue":"8","key":"1226_CR33","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/0002-9378(81)90082-X","volume":"140","author":"AK Kreutner","year":"1981","unstructured":"Kreutner AK, Del Bene VE, Amstey MS. Giardiasis in pregnancy. Am J Obstet Gynecol. 1981;140(8):895\u2013901.","journal-title":"Am J Obstet Gynecol"},{"key":"1226_CR34","doi-asserted-by":"crossref","unstructured":"De Waele J, Lipman J. Akova M, Vassetti M, Dimpoulos G, Kaukonon M et al. Risk factors for target non-attainment during empirical treatment with b-lactam antibiotics in critically ill patients. Intensive Care Med. 2014; 1340\u201351.","DOI":"10.1007\/s00134-014-3403-8"},{"issue":"8","key":"1226_CR35","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3390\/pharmaceutics13081302","volume":"13","author":"SAM Brookhuis","year":"2021","unstructured":"Brookhuis SAM, Allegaert K, Hanff LM, Lub-deHooge MN, Dallmann A, Mian P. Modelling tools to characterize acetaminophen pharmacokinetics in the pregnant population. Pharmaceutics. 2021;13(8):130.","journal-title":"Pharmaceutics"}],"container-title":["Clinical Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-023-01226-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40262-023-01226-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-023-01226-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T05:47:07Z","timestamp":1679896027000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40262-023-01226-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["1226"],"URL":"https:\/\/doi.org\/10.1007\/s40262-023-01226-6","relation":{},"ISSN":["0312-5963","1179-1926"],"issn-type":[{"value":"0312-5963","type":"print"},{"value":"1179-1926","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"12 February 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research did not receive any grants from funding agencies in the public, commercial, or not-for-profit sectors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Femke Groen, Jelmer R. Prins, Marjolijn N. Lub-de Hooge, Rik L.J. Winter, Jos G.W. Kosterink, Daniel J. Touw and Paola Mian declare that they have no financial or non-financial interests that are directly or indirectly related to the work submitted for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest\/competing interests"}},{"value":"FG contributed to the literature search, data extraction, data analysis and writing the initial draft of the manuscript. JRP, MNLDH, HLJW, JGWK contributed to study design and DJT contributed to conceptualization of the study, data analysis and reviewing the manuscript. PM contributed to the conceptualization of the study, literature search, data extraction, data analysis and writing and reviewing the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}